Table 3 Geographical representation in the original studies supporting the 2021 Surviving Sepsis Campaign guidelines based on World Bank classification for regions
Recommendation | Studies (n) | East Asia Pacific n (%) | Europe Central Asia n (%) | Latin America Caribbean n (%) | Middle East North Africa n (%) | North America n (%) | South Asia n (%) | Sub-Saharan Africa n (%) |
|---|---|---|---|---|---|---|---|---|
Screening & Early Treatment | 30* | 2 (7) | 10 (33) | 4 (13) | 1 (3) | 14 (47) | 0 (0) | 4 (13) |
Infection | 126* | 25 (20) | 55 (44) | 12 (10) | 9 (7) | 54 (43) | 3 (2) | 8 (6) |
Hemodynamic Management | 47* | 9 (19) | 16 (34) | 1 (2) | 3 (6) | 25 (53) | 0 (0) | 1 (2) |
Ventilation | 41* | 8 (20) | 27 (66) | 10 (24) | 5 (12) | 19 (46) | 0 (0) | 1 (2) |
Additional Therapies | 36* | 3 (8) | 19 (53) | 2 (6) | 2 (6) | 13 (36) | 2 (6) | 0 (0) |
Long Term Outcomes/ Goals of Care | 83 | 7 (8) | 31 (37) | 0 (0) | 0 (0) | 46 (55) | 0 (0) | 0 (0) |